Quarterly ResultAug 5, 2026, 04:59 PM
LifeMD Q2 Revenue Down to $47.28M; Net Loss Widens to $7.86M
AI Summary
LifeMD, Inc. reported a net loss of $7.86 million for the second quarter of 2026, a significant increase from the $2.40 million loss in the same period last year. Telehealth revenue for Q2 2026 decreased to $47.28 million from $49.02 million year-over-year. For the six months ended June 30, 2026, the company's net loss widened to $17.51 million from $3.36 million in the prior year. The company also noted an accumulated deficit of $246.1 million and negative working capital of $4.5 million as of June 30, 2026, but expects to fund operations for at least the next 12 months.
Key Highlights
- Q2 2026 net loss attributable to common stockholders was $(7.86) million, compared to $(2.40) million in Q2 2025.
- Q2 2026 telehealth revenue decreased to $47.28 million from $49.02 million in Q2 2025.
- Basic loss per share for Q2 2026 was $(0.16), compared to $(0.05) in Q2 2025.
- Six-month net loss was $(17.51) million, significantly wider than $(3.36) million in prior year.
- Accumulated deficit reached $(246.1) million as of June 30, 2026.
- Negative working capital of $(4.5) million reported as of June 30, 2026.
- Entered a $30 million revolving credit facility and has $44.6 million available under ATM sales agreement.
- Received a waiver for non-compliance with a Consolidated Interest Coverage Ratio covenant.
Price Impact
More from LFMD